Related Experiment Videos
Sulfamethoxazole-induced hepatic injury
Digestive Diseases and Sciences
|August 1, 1981
Summary
Sulfamethoxazole can cause jaundice through a rare hypersensitivity reaction, presenting a pure cholestatic pattern unlike typical sulfonamide liver injury. This case highlights a unique drug-induced liver injury mechanism.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Immunology
Background:
- Sulfonamides, including sulfamethoxazole, are known to cause drug-induced liver injury (DILI).
- Hepatotoxicity from sulfonamides typically manifests as hepatocellular necrosis or cholestasis.
- Hypersensitivity reactions are a recognized mechanism for DILI.
Observation:
- A patient experienced recurrent jaundice episodes linked to sulfamethoxazole treatment.
- Histological examination revealed a predominantly cholestatic pattern, distinct from usual sulfonamide-induced hepatocellular damage.
- Clinical presentation and drug challenge response suggested a hypersensitivity-mediated reaction.
Findings:
- The patient's liver injury pattern was characterized by pure cholestasis.
- Lymphocyte studies showed no in vitro blast transformation in response to sulfamethoxazole.
- This suggests a non-T-cell mediated hypersensitivity or an atypical immune response.
Implications:
- This case expands the understanding of sulfamethoxazole-induced liver injury, demonstrating a rare pure cholestatic presentation.
- It underscores the importance of considering hypersensitivity mechanisms in DILI, even with atypical histological findings.
- Further research may be needed to elucidate the precise immunological pathways involved in such reactions.